<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976686</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01262</org_study_id>
    <nct_id>NCT04976686</nct_id>
  </id_info>
  <brief_title>Low Carbohydrate Small Intestine Study</brief_title>
  <official_title>Studying the Impact of a Low Carbohydrate Diet on the Small Intestinal Microbiota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will recruit probands with a ileo- or colostoma that are otherwise in good&#xD;
      general health and analyse the stomal fluids for their microbiota composition. Sampling will&#xD;
      be performed over a time span of 28 days, after 14 days probands will modify their base-line&#xD;
      diet to a low carbohydrate diet.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Additionally to stoma fluids which will be analyzed for their microbiota composition the&#xD;
      investigators will also collect skin samples to analyze for microbiota composition and urine&#xD;
      to analyze for metabolite composition.&#xD;
&#xD;
      Low carbohydrate diet will allow for consumption of 80g complex carbohydrates per day, simple&#xD;
      sugars will have to be avoided completely&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>First phase will be purely observational, second phase involves diet modification</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of microbiota profile by 16S sequencing before and after diet modification for significant differences</measure>
    <time_frame>28 days</time_frame>
    <description>Sample content will be measured by 16S sequencing, ecological distances will be assessed by beta-diversity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relative changes of total metabolite abundance in urine</measure>
    <time_frame>28 days</time_frame>
    <description>The whole metabolite composition will be assessed by an untargeted screen done with mass spectrometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of microbiota metabolic potential (microbiome DNA coding for enzymes) after shotgun sequencing</measure>
    <time_frame>28 days</time_frame>
    <description>The total DNA content of the samples will be annotated for for known metabolic active enzymes to assess functionality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of microbiota biomass</measure>
    <time_frame>28 days</time_frame>
    <description>The samples will be analysed for the number of bacteria present in them</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of further metagenomic microbiome composition (viral, eucaryotic DNA)</measure>
    <time_frame>28 days</time_frame>
    <description>The DNA of the samples will be screened for parts belonging to viruses or eucaryotic cells</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Culturing of microbiota if appropriate (in vitro)</measure>
    <time_frame>28 days</time_frame>
    <description>If of interest, culturing of specific bacterial strains will be attempted in vitro with the aim to recreate in vivo observations</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diet, Healthy</condition>
  <arm_group>
    <arm_group_label>All study participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will undergo sample collection during their regular diet and after modification of their diet to a low carbohydrate diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet modification</intervention_name>
    <description>Participants will reduce their carbohydrate consumption to 80g daily</description>
    <arm_group_label>All study participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ileostomy or colostomy&#xD;
&#xD;
          -  Good general health&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major metabolic diseases that prevent adherence to low carbohydrate diet&#xD;
&#xD;
          -  Participation in other clinical trial interfering with study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Misselwitz, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinic for Visceral Surgery and Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Misselwitz, Prof. Dr. med.</last_name>
    <phone>31 632 59 00</phone>
    <phone_ext>+41</phone_ext>
    <email>benjamin.misselwitz@dbmr.unibe.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 12, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Sharing of raw sequencing data as electronic supplement to publication (e.g. by entry on database)</ipd_description>
    <ipd_time_frame>upon publication, unlimited</ipd_time_frame>
    <ipd_access_criteria>Open access</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

